The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome

Background: Turner syndrome (TS) is the most common chromosomal abnormality in females. The diagnosis of TS is based on karyotyping of 30 blood lymphocytes. This technique does not rule out tissue mosaicism or low-grade mosaicism in the blood. Because of the associated risk of gonadoblastoma, mosaic...

Full description

Saved in:
Bibliographic Details
Main Authors: Heba Mohamed Ossama, Soha Kholeif, Ghada Mohamed Elhady
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-10-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jhrs.jhrs_128_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860918668230656
author Heba Mohamed Ossama
Soha Kholeif
Ghada Mohamed Elhady
author_facet Heba Mohamed Ossama
Soha Kholeif
Ghada Mohamed Elhady
author_sort Heba Mohamed Ossama
collection DOAJ
description Background: Turner syndrome (TS) is the most common chromosomal abnormality in females. The diagnosis of TS is based on karyotyping of 30 blood lymphocytes. This technique does not rule out tissue mosaicism or low-grade mosaicism in the blood. Because of the associated risk of gonadoblastoma, mosaicism is especially important in case this involves a Y chromosome. Aims: This study was set to determine the value of additional genetic studies such as fluorescent in situ hybridisation and the inclusion of buccal cells in search for mosaicism in TS patients. Settings and Design: This cross-sectional, descriptive study was performed in Human Genetics Department, Medical Research Institute, Alexandria University. Materials and Methods: Fluorescence in situ hybridisation technique was applied to lymphocyte cultures as well as buccal smears using centromeric probes for X and Y chromosomes. Genotype phenotype correlation was also evaluated. Statistical Analysis Used: Descriptive study where categorical variables were described using number and percentage and continuous variables were described using mean and standard deviation. Results: Fluorescence in situ hybridisation technique study detected hidden mosaicism in 60% of studied patients; 20% of patients had a cell line containing Y material, while 40% had variable degrees of X, XX mosaicism, and in the remaining 40% no second cell line was detected. Fluorescence in situ hybridisation study helped identify the origin of the marker to be Y in all patients. The introduction of an additional cell line helped in identifying mosaicism in patients with monosomy X. Virilisation signs were only observed among TS patients with Y cell line mosaicism. The clinical manifestations were more severe in patients with monosomy X than other mosaic cases. Conclusions: Molecular cytogenetic investigation for all suspected cases of TS should be considered for appropriate treatment plan and genetic counselling.
format Article
id doaj-art-b5945e8a22c3411fa042b6e08dfefb1a
institution Kabale University
issn 0974-1208
1998-4766
language English
publishDate 2023-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Human Reproductive Sciences
spelling doaj-art-b5945e8a22c3411fa042b6e08dfefb1a2025-02-10T09:11:15ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662023-10-0116428629810.4103/jhrs.jhrs_128_23The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner SyndromeHeba Mohamed OssamaSoha KholeifGhada Mohamed ElhadyBackground: Turner syndrome (TS) is the most common chromosomal abnormality in females. The diagnosis of TS is based on karyotyping of 30 blood lymphocytes. This technique does not rule out tissue mosaicism or low-grade mosaicism in the blood. Because of the associated risk of gonadoblastoma, mosaicism is especially important in case this involves a Y chromosome. Aims: This study was set to determine the value of additional genetic studies such as fluorescent in situ hybridisation and the inclusion of buccal cells in search for mosaicism in TS patients. Settings and Design: This cross-sectional, descriptive study was performed in Human Genetics Department, Medical Research Institute, Alexandria University. Materials and Methods: Fluorescence in situ hybridisation technique was applied to lymphocyte cultures as well as buccal smears using centromeric probes for X and Y chromosomes. Genotype phenotype correlation was also evaluated. Statistical Analysis Used: Descriptive study where categorical variables were described using number and percentage and continuous variables were described using mean and standard deviation. Results: Fluorescence in situ hybridisation technique study detected hidden mosaicism in 60% of studied patients; 20% of patients had a cell line containing Y material, while 40% had variable degrees of X, XX mosaicism, and in the remaining 40% no second cell line was detected. Fluorescence in situ hybridisation study helped identify the origin of the marker to be Y in all patients. The introduction of an additional cell line helped in identifying mosaicism in patients with monosomy X. Virilisation signs were only observed among TS patients with Y cell line mosaicism. The clinical manifestations were more severe in patients with monosomy X than other mosaic cases. Conclusions: Molecular cytogenetic investigation for all suspected cases of TS should be considered for appropriate treatment plan and genetic counselling.https://journals.lww.com/10.4103/jhrs.jhrs_128_23fluorescent in situ hybridisationmosaicismturner syndrome
spellingShingle Heba Mohamed Ossama
Soha Kholeif
Ghada Mohamed Elhady
The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
Journal of Human Reproductive Sciences
fluorescent in situ hybridisation
mosaicism
turner syndrome
title The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
title_full The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
title_fullStr The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
title_full_unstemmed The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
title_short The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
title_sort use of fluorescence in situ hybridisation in the diagnosis of hidden mosaicism in egyptian patients with turner syndrome
topic fluorescent in situ hybridisation
mosaicism
turner syndrome
url https://journals.lww.com/10.4103/jhrs.jhrs_128_23
work_keys_str_mv AT hebamohamedossama theuseoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome
AT sohakholeif theuseoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome
AT ghadamohamedelhady theuseoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome
AT hebamohamedossama useoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome
AT sohakholeif useoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome
AT ghadamohamedelhady useoffluorescenceinsituhybridisationinthediagnosisofhiddenmosaicisminegyptianpatientswithturnersyndrome